LIFECORE BIOMEDICAL, INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
LIFECORE BIOMEDICAL, INC. (LFCR) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax of $16.00 thousand for the 12-month period ending 2023-05-28, per its 10-K filed 2024-08-26.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax · last filed 2024-08-26
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2023-05-28 was $0.00.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2023-02-26 was $0.00.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2022-11-27 was $16.00K.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2022-08-28 was $16.00K.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2023 was $16.00K.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2022 was -$430.00K.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2021 was -$455.00K, a 151.82% decline from fiscal 2020.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2020 was $878.00K, a 211.35% increase from fiscal 2019.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 6 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 9 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 12 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-05-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $0.00 derived: sum of 2 quarters · filed 2024-08-26 | $16.00K derived: sum of 3 quarters · filed 2024-08-26 | $16.00K 10-K · filed 2024-08-26 | ||||
| 2023-02-26 | $0.00 10-Q · filed 2023-06-02 | $16.00K derived: sum of 2 quarters · filed 2024-08-09 | $16.00K 10-Q · filed 2024-08-09 | -$16.00K 10-Q · filed 2023-06-02 | -$208.00K derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-11-27 | $16.00K 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2023-03-16 | $16.00K 10-Q · filed 2024-08-09 | -$16.00K 10-Q · filed 2023-03-16 | -$208.00K derived: sum of 3 quarters · filed 2024-08-26 | -$308.00K derived: sum of 4 quarters · filed 2024-08-26 | ||
| 2022-08-28 | $16.00K 10-Q · filed 2024-08-09 | -$16.00K 10-Q · filed 2022-10-07 | -$224.00K derived: sum of 2 quarters · filed 2024-08-26 | -$324.00K derived: sum of 3 quarters · filed 2024-08-26 | -$424.00K derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-05-29 | -$240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | -$340.00K derived: sum of 2 quarters · filed 2024-08-26 | -$440.00K derived: sum of 3 quarters · filed 2024-08-26 | -$430.00K 10-K · filed 2024-08-26 | -$445.00K 10-K · filed 2022-09-14 | |||
| 2022-02-27 | -$100.00K 10-Q · filed 2023-06-02 | -$101.00K 10-Q · filed 2022-04-07 | -$200.00K derived: sum of 2 quarters · filed 2023-06-02 | -$190.00K 10-Q · filed 2023-06-02 | -$291.00K 10-Q · filed 2022-04-07 | -$418.00K derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2021-11-28 | -$100.00K 10-Q · filed 2023-03-16 | -$190.00K 10-Q · filed 2023-03-16 | -$318.00K derived: sum of 3 quarters · filed 2024-03-20 | -$417.00K derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-08-29 | -$90.00K 10-Q/A · filed 2023-03-16 | -$218.00K derived: sum of 2 quarters · filed 2024-03-20 | -$317.00K derived: sum of 3 quarters · filed 2024-03-20 | -$438.00K derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-05-30 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$227.00K derived: sum of 2 quarters · filed 2024-03-20 | -$348.00K derived: sum of 3 quarters · filed 2024-03-20 | -$455.00K 10-K · filed 2024-03-20 | $878.00K 10-K · filed 2021-07-29 | |||
| 2021-02-28 | -$99.00K 10-Q · filed 2022-04-07 | $99.00K 10-Q · filed 2021-04-08 | -$220.00K derived: sum of 2 quarters · filed 2022-04-07 | -$327.00K 10-Q · filed 2022-04-07 | $327.00K 10-Q · filed 2021-04-08 | $842.00K derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2020-11-29 | -$121.00K 10-Q · filed 2022-01-07 | $121.00K 10-Q · filed 2021-01-07 | -$228.00K 10-Q · filed 2022-01-07 | $228.00K 10-Q · filed 2021-01-07 | $941.00K derived: sum of 3 quarters · filed 2023-03-16 | $817.00K derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2020-08-30 | -$121.00K 10-Q · filed 2021-10-05 | $1.06M derived: sum of 2 quarters · filed 2023-03-16 | $938.00K derived: sum of 3 quarters · filed 2023-03-16 | $977.00K derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-05-31 | $1.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $1.06M derived: sum of 2 quarters · filed 2023-03-16 | $1.10M derived: sum of 3 quarters · filed 2023-03-16 | $878.00K 10-K/A · filed 2023-03-16 | $282.00K 10-K · filed 2020-08-14 | |||
| 2020-02-23 | -$124.00K 10-Q · filed 2021-04-08 | $124.00K 10-Q · filed 2020-04-03 | -$85.00K derived: sum of 2 quarters · filed 2021-04-08 | -$305.00K 10-Q · filed 2021-04-08 | $305.00K 10-Q · filed 2020-04-03 | |||
| 2019-11-24 | $39.00K 10-Q · filed 2021-01-07 | -$39.00K 10-Q · filed 2020-01-02 | -$226.00K 10-Q · filed 2021-01-07 | $226.00K 10-Q · filed 2020-01-02 | ||||
| 2019-08-25 | $265.00K 10-Q · filed 2020-10-07 | |||||||
| 2019-05-26 | $282.00K 10-K · filed 2021-07-29 | $878.00K 10-K · filed 2020-08-14 | ||||||
| 2018-05-27 | -$123.00K 10-K · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |